MSF Access Campaign Profile picture
We advocate for access to & development of lifesaving medicines, tests & vaccines for people in MSF programmes & beyond. #MedicinesShouldntBeALuxury

Jun 2, 2022, 11 tweets

Cardiovascular disease 🫀 is the world’s biggest killer, representing 32% of all global deaths.

Hypertension, or high blood pressure, is a major risk factor for cardiovascular disease. 🧵 1/11

#Hypertension is a “silent killer” as most people with hypertension are not aware of their diagnosis. 2/11

Treatment for hypertension involves multiple steps and medicines which make it difficult for patients to follow through and manage their treatment.

The price of medicines is also a major challenge in some places. 3/11

Combination medicines which would make treatment simpler for patients and healthcare providers alike exist and are recommended by @WHO.

So why are they not widely used?
4/11

In @MSF projects, more than three-quarters of patients need two or more #hypertension medicines.

The introduction of single-pill combinations into these projects, however, has been a challenge. 5/11

The🆕report "Under Pressure", explains why this is the case and identifies what @WHO, donors, member states, civil society, and pharmaceutical industry can do to help improve access to single-pill combinations.
msfaccess.org/hypertension-r…
6/11
@ResolveTSL @CHAI_health @worldheartfed

The report has the following major findings:

⚡️Generic hypertension medicine prices vary substantially across the low- and middle-income countries (LMICs) studied. 7/11

⚡️Despite being recommended by WHO, single-pill combination medicines are often unavailable or unaffordable to patients, even though estimates have shown that combination pills can cost less to produce. 8/11

⚡️ At current prices, many LMIC governments do not offer affordable and safe essential medical treatment to people living with hypertension. 9/11

“With less than 10% of people living with hypertension having their blood pressure controlled in low- and middle-income countries, we need to simplify how we deliver hypertension treatment.” 10/11

What needs to be done?

Governments need to prioritise single-pill combinations and promote transparency around the pricing of anti-hypertensive drugs.

How?

For more details, read the report “Under Pressure”

msfaccess.org/hypertension-r…

11/11

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling